Home › Therapeutic areas › Neurology › Attention Deficit Hyperactivity Disorder

Attention Deficit Hyperactivity Disorder (3 companies)

Companies with an active program in Attention Deficit Hyperactivity Disorder.

Ticker Company Therapeutic areas Programs Lead stage Programs
AXSM Axsome Therapeutics Neurology Rare 1 Approved 15
CING Cingulate Neurology 1 NDA Submitted 1
RVPH Reviva Pharmaceuticals CardiovascularDermatology+2 Rare 1 Phase 3 10